BPC-157 Dosing for Tendon Repair Common Protocols Conservative approach (8-week cycle): Dose: 250-500mcg per day Route: Subcutaneous injection Frequency: Daily Duration: 8-12 weeks Break: 4 weeks between cycles Aggressive approach (ongoing): Dose: 500mcg daily for 6 weeks Then: 250mcg 2-3x weekly maintenance Route: Subcutaneous or intranasal Duration: Continuous until injury resolved Localized injection (advanced): Direct injection into injured tendon (medical supervision required) Dose: 250-500mcg Frequency: 1-2x weekly Duration: 4-8 weeks Results: May be superior, but requires qualified practitioner Administration Routes Subcutaneous (most common): 250-500mcg in 0.5mL water, injected daily Painless, stable delivery Consistent blood levels Intranasal: 250mcg sprayed into nostrils daily Non-invasive, good absorption Less evidence but growing anecdotal support Oral: Limited effectiveness (degraded by stomach acid) Not recommended for serious injury recovery Real-World Results: Athlete Case Studies Case 1: Chronic Patellar Tendinopathy (Runner) Situation : 3 years of patellar tendon pain, limiting running to 3 miles max Protocol : BPC-157: 500mcg daily for 8 weeks Eccentric loading exercises 3x weekly Return to training protocol structured over 12 weeks Result : After 4 months, pain-free running at pre-injury distances
Most of the time, you'll hear numbers like 250 to 500 mg daily tossed aroundespecially from functional medicine folks
miR-20a and miR-4853p can reduce iron output by targeting FPN genes [127, 128], miR-200b, and miR-let-7d effectively reducing iron accumulation by inhibiting the expression of FTH, DMT1, and iron response element (IRE) [129, 130]
The long-term efficacy of Semaglutide (used in Ozempic and Wegovy ) and Mounjaro (tirzepatide) in weight maintenance has been a subject of continuous study and interest within the medical community
This step is the rate-limiting step of GSH synthesis and is regulated by cysteine availability
Mounjaro & Zepbound: 3 days to administer a late dose
